Log in to save to my catalogue

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1560134688

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma

About this item

Full title

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma

Publisher

Basel: Springer Basel

Journal title

Inflammation research, 2014-09, Vol.63 (9), p.789-796

Language

English

Formats

Publication information

Publisher

Basel: Springer Basel

More information

Scope and Contents

Contents

Objective and design
An open-label, non-randomized, single-arm study was performed to investigate the safety and efficacy of high-dose leukocytapheresis (pulse LCAP) for refractory asthma.
Subjects
Six patients who fulfilled the ATS workshop criteria for refractory asthma were enrolled and completed this clinical study.
Treatment
Aft...

Alternative Titles

Full title

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1560134688

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1560134688

Other Identifiers

ISSN

1023-3830

E-ISSN

1420-908X

DOI

10.1007/s00011-014-0753-1

How to access this item